Navigation Links
Summer Street Research Announces Expansion of Research Team with the Addition of Ling Wang, CFA, Senior Biotechnology Analyst
Date:7/14/2011

BOSTON, July 14, 2011 /PRNewswire/ -- Summer Street Research Partners announced today that Ling Wang, CFA, has joined the firm as senior biotechnology analyst, director. She will be focused on covering the biotechnology sector, continuing to build out the biotechnology sector for the firm. Ms. Wang joins the firm with years of equity research experience.  

"We are very excited to welcome Ling to the research team at Summer Street. Ling is a proven analyst with extensive Wall Street experience," says Dr. Mark Landy, director of research for Summer Street Research. "We believe Ling will bring valuable insights and a unique perspective to our research product, which will benefit our clients."

Prior to joining Summer Street, Ms. Wang was a senior vice president and senior biotechnology analyst at Brean Murray, Carret & Co. since 2009. Prior to Brean Murray, she was a research associate covering biotechnology stocks at Rodman & Renshaw from 2006 to 2008. Prior to that, she was a research assistant in the life science group at Manning & Napier Advisors, Inc. (an investment firm with approximately $16 billion assets under management) from 2004 to 2006. Ms. Wang earned her undergraduate degree in biology from Beijing University. She also holds a master's degree in molecular pharmacology from Albert Einstein College of Medicine and an MBA degree in finance from Yale University.

"I'm very excited to join Summer Street," Ms. Wang says. "With their unique MCRI consulting network and their singular focus on the healthcare sector, I believe Summer Street is the right platform for me to add real value to institutional healthcare investors on important and timely topics."  

About Summer Street Research, Inc.

Summer Street Research Partners is an investment banking, institutional equity research and trading firm that focuses exclusively on the healthcare sector. Our mission is to help our clients maximize returns by providi
'/>"/>

SOURCE Summer Street Research Partners
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Summer Street Research Partners Closes Financing for ImmunoCellular Therapeutics, Ltd.
2. Expanded Lipoprotein Testing, VAP® Cholesterol Test Discussed at National Lipid Association Summer Clinical Lipid Update
3. Cellectis to Present at the FASEB Summer Research Conference on Genome Engineering
4. Health Robotics and McKesson to Showcase i.v.STATION and i.v.SOFT at ASHPs Summer Meeting, Tampa, June 6-8, 2010
5. Summerhill Biomass Systems Unveils Solid Biomass Technology System at Syracuse Expo
6. ECBC Now Accepting Applications for 2009 Minority Undergraduate Summer Internship Program
7. LI-COR Updates Product and Application Guide for Summer 2008
8. Veteran Wall Street Securities Analyst Reports on Health Discovery Corporation
9. Scott Garrett Joins Water Street Healthcare Partners
10. NeoStem to Present at Wall Street Forum 2011 Financial Conference on Tuesday, March 1
11. Aethlon Medical to Present at the Wall Street Analyst Forum 22nd Annual Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... 2015 Knowledgent , the data ... explores the potential of big data analytics in the ... developed to help life sciences and healthcare organizations understand ... gain critical business insights. , The life sciences and ... driven by patient profiling, compliance and regulatory requirements, and ...
(Date:5/21/2015)... Specialty Pharmacy Times has completed ... to BPA Worldwide as a business publication member. ... data for Specialty Pharmacy Times based on business/distribution, ... a member of BPA Worldwide, Specialty Pharmacy Times ... with the most reliable, unequaled data,” said Chris ...
(Date:5/21/2015)... May 21, 2015  The EveryLife Foundation for ... (R-UT) and Amy Klobuchar (D-MN) today ... Cures & Treatments, or OPEN ACT. ... advocacy organizations, this bipartisan legislation promises to rapidly ... to rare disease patients by incentivizing drug makers ...
(Date:5/21/2015)... , May 21, 2015  CytRx Corporation (NASDAQ: ... company specializing in oncology, today announced positive updated ... with aldoxorubicin for the treatment of unresectable glioblastoma ...  The open-label, multisite trial is designed to investigate ... patients whose tumors have progressed following prior treatment ...
Breaking Biology Technology:New White Paper Explores the Potential of Big Data Analytics in Life Sciences and Healthcare 2Specialty Pharmacy Times Joins BPA Worldwide 2Advocates Cheer Senate Leaders for Introducing Bipartisan Bill to Increase Number of Rare Disease Treatments 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7
... Researchers in California today (Oct. 17) report development of ... waves wirelessly and converts them to sound signals through ... nanotube radio device is thousands of times smaller than ... an important step in the evolution of nano-electronics and ...
... Arena Pharmaceuticals,Inc. (Nasdaq: ARNA ) today reported ... Total revenues in the third quarter of 2007 ... quarter of 2006. Total revenues in the first,nine months ... in the,first nine months of 2006. Revenues in the ...
... Oct. 17 Navitas Cancer Rehabilitation Centers,of America, ... and,comprehensive cancer rehabilitation services, is pleased to announce ... Corporate Medical Director. In addition to currently ... Paul area, Dr. Gesme has served as the ...
Cached Biology Technology:Arena Pharmaceuticals Announces Third Quarter 2007 Financial Results 2Arena Pharmaceuticals Announces Third Quarter 2007 Financial Results 3Arena Pharmaceuticals Announces Third Quarter 2007 Financial Results 4Arena Pharmaceuticals Announces Third Quarter 2007 Financial Results 5Arena Pharmaceuticals Announces Third Quarter 2007 Financial Results 6Arena Pharmaceuticals Announces Third Quarter 2007 Financial Results 7Navitas Names Dr. Dean Gesme as Medical Director 2
(Date:5/6/2015)... 6, 2015 LifeBEAM, a developer of bio-sensing ... announced today that they will expand their partnership in ... bio-sensing cycling helmet and the first joint project between ... colors in order to give cyclists more style choices ... LifeBEAM and Lazer announced their plan to release a ...
(Date:4/21/2015)... 21, 2015 High crime ... are boosting access control systems market in ... a recently published report by TechSci Research " Saudi ... access control systems market in Saudi Arabia ... 2020.The access control systems market in the Kingdom is ...
(Date:4/14/2015)... Conn. , April 14, 2015 NXT-ID, ... a biometric authentication company focused on the growing mobile ... been nominated for the 2015 New York Design Awards ... The Design100, New York City Design Awards are part ... based on over 2,500 ratings from the marketplace, industry ...
Breaking Biology News(10 mins):LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3
... LAFAYETTE, Ind. - Sanitizing the outside of produce may not ... Purdue University study that demonstrated that Salmonella and E. ... E. coli 0157:H7 was present in tissues of mung ... seeds were contaminated with the pathogens prior to planting. Amanda ...
... an international team including professor John Graves of the Virginia ... tunas and billfishes are threatened and in need of further ... Science magazine,s Policy Forumis the first study of ... International Union for Conservation of Nature (IUCN). ,The IUCN Red ...
... time when instead of just drinking that morning cup of ... of preventing harmful sun damage or skin cancer., A new ... skin cancers at the molecular level by inhibiting a protein ... based on what they have learned studying mice, caffeine applied ...
Cached Biology News:E. coli, salmonella may lurk in unwashable places in produce 2Study helps assess global status of tuna and billfish stocks 2Study helps assess global status of tuna and billfish stocks 3More evidence that caffeine lowers risk of skin cancer 2
Ready for formulation or direct injection into animals Provided in convenient 100, 250, 1000 and 10,000 nmol sizes HPLC purified, salt free, sterile filtered, and endotoxin tested ...
... siRNA service provides the premium quality siRNAs ... Custom siRNAs can be readily ordered online ... sequence, or by providing the sense and ... Silencer Validated and Silencer ...
GEL FILTRATION CAL KIT HMW, 1 EA. *Category: Gel Filtration Gels....
Mouse monoclonal [6C3] to JAB1 ( Abpromise for all tested applications). entrezGeneID: 10987 SwissProtID: O15386...
Biology Products: